Luc-Mathieu Fornecker

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag, Serge Koscielny, Jacques Bosq et al. · The Lancet · 2016 · 187 citations

Medicine, Oncology, Pharmacotherapy +9

Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS

Roch Houot, Steven Le Gouill, Christiane Mounier et al. · Annals of Oncology · 2011 · 44 citations · Full text

Medicine, Hematology, Oncology +14

Survival effect of darbepoetin alfa in patients with diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: The LNH03-6B study.

Richard Delarue, Corinne Haïoun, Bertrand Coiffier et al. · Journal of Clinical Oncology · 2011 · 23 citations

Medicine, Hematology, Oncology +17

Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial

Romain Guièze, Loïc Ysebaert, Damien Roos‐Weil et al. · Nature Communications · 2024 · 12 citations · Full text

Medicine, Hematology, Oncology +17